The Business Account Executive is responsible for identifying healthcare providers and accounts to increase brand awareness and product adoption for TTR amyloidosis treatments. They will develop and execute territory strategies while collaborating with internal and external stakeholders to achieve sales targets.
The Case Manager assesses patient needs to develop action plans for treatment initiation and maintenance while coordinating with internal and external stakeholders. They manage the reimbursement process, including insurance approvals, billing, and patient assistance programs to ensure seamless access to therapy.
The Associate Case Manager is responsible for verifying insurance coverage, managing patient referrals, and coordinating therapy access services. They also maintain accurate patient data, track specialty pharmacy referrals, and provide support to the broader Patient Services team.
The Senior Manager, Study Start-up leads global site activation and study start-up activities, ensuring predictable delivery through data-driven forecasting and CRO oversight. They also develop and implement processes to optimize clinical trial timelines and remove operational obstacles for site activation.
The Senior Manager is responsible for the strategic planning, development, and implementation of training programs for Market Access and Strategic Accounts teams. They will collaborate cross-functionally to ensure compliant delivery of training materials and use performance data to drive continuous improvement.
The Health System Medical Outcomes Science Liaison serves as a field-based scientific expert, engaging with formulary decision-makers and C-suite leaders to communicate the clinical and economic value of Alnylam's portfolio. They are responsible for developing account-specific strategic plans, identifying research collaboration opportunities, and supporting evidence-based decision-making within health systems.
The Business Account Executive is responsible for selling RNAi therapeutics within the assigned territory. They will drive business growth by engaging with healthcare professionals and stakeholders.
The Business Account Executive is responsible for identifying and targeting healthcare providers to increase brand awareness and product adoption for TTR amyloidosis treatments. They will develop and execute territory-level business plans while collaborating with internal and external stakeholders to manage regional business objectives.
The Associate Director leads the Site and Monitoring Health strategy to ensure high-quality clinical trial execution and effective CRO oversight. They manage regional leads and FSP vendors while driving process improvements and maintaining inspection readiness across the clinical portfolio.
The Principal Medical Writer leads the development of clinical documents and represents medical writing on multi-disciplinary teams. They are responsible for overseeing contract writers, ensuring regulatory compliance, and facilitating the review process for clinical documentation.
The Associate Director will lead the national strategy and execution for US congress presence and Thought Leader Liaison (TLL) marketing initiatives. This role involves managing cross-functional collaborations, overseeing KOL insight processes, and ensuring all educational content is scientifically accurate and compliant.
The Business Account Executive is responsible for identifying and targeting healthcare providers to increase brand awareness and product adoption for TTR amyloidosis treatments. They must build and maintain strategic relationships with physicians and internal stakeholders to achieve territory sales targets.
The Key Account Manager is responsible for developing and implementing strategic account plans to drive commercial objectives and optimize patient care within their assigned territory. They will manage relationships with healthcare professionals, identify treatment centers, and ensure the effective promotion of RNAi platform products.
The Business Account Executive is responsible for identifying and targeting healthcare providers to increase brand awareness and product adoption for TTR amyloidosis treatments. They will develop and execute account strategies while collaborating with internal and external stakeholders to achieve territory sales targets.
The Business Account Executive is responsible for identifying healthcare providers and managing accounts to increase brand awareness and product adoption for TTR amyloidosis treatments. They will collaborate with internal and external stakeholders to develop account strategies and achieve territory sales targets.
The Business Account Executive is responsible for managing business accounts and driving sales growth within the organization. They will focus on building relationships and promoting RNAi therapeutics to address rare and common diseases.
The role involves working diligently to complete assigned tasks. Employees are expected to meet all established deadlines.
The Business Account Executive is responsible for driving physician and patient identification, disease awareness, and market development within the assigned territory. They will manage account strategies, collaborate with internal and external stakeholders, and execute promotional programs to achieve sales objectives.
Develop and implement capability-building strategies and learning solutions to drive field performance within the TTR franchise. Collaborate cross-functionally to design high-impact training experiences and manage the onboarding and continuous learning programs for the commercial team.
Lead the multi-year roadmap and business ownership for Quality digital capabilities including SAP, Veeva, and LIMS. Act as the primary bridge between Quality and IT to translate business needs into scalable, compliant digital requirements and ensure data integrity.
The MSL is responsible for building scientific partnerships with KOLs and healthcare professionals to elevate disease understanding of TTR amyloidosis. They will deliver scientific information, gather medical insights, and support clinical trial patient accrual within the Ohio Valley geography.
Drive the operational excellence and effectiveness of customer-facing field teams across Commercial and Medical Affairs. Translate business strategies into actionable execution frameworks through KPI management, reporting, and field alignment.
Lead the clinical development strategies for cardiology and cardiometabolic health programs to secure global regulatory approvals. Collaborate across matrix teams and provide strategic guidance to research groups on the feasibility of novel targets.
The Business Account Executive is responsible for driving patient identification, disease awareness, and brand awareness for GIVLAARI and OXLUMO within a specific territory. This involves executing account strategies, collaborating with internal stakeholders, and managing relationships with healthcare providers to achieve sales targets.
Assess patient needs and develop action plans to initiate and maintain treatment with Alnylam products. Coordinate with internal and external stakeholders to navigate reimbursement, insurance approvals, and patient assistance programs.
Lead the strategy and oversight of US patient field-facing teams, including Case Management and Patient Education Liaisons. Ensure a seamless end-to-end patient experience from education and reimbursement through treatment initiation and continuity of care.
The Business Account Executive is responsible for identifying healthcare providers and accounts to increase brand awareness and adoption of AMVUTTRA for TTR amyloidosis. This involves developing strategic account plans and collaborating with internal stakeholders to ensure patient access at the site of care.
The Business Account Executive is responsible for identifying healthcare providers and accounts to increase brand awareness and adoption of AMVUTTRA for TTR amyloidosis. This involves developing account plans, collaborating with cross-functional stakeholders, and executing sales strategies to achieve territory targets.
The Business Account Executive is responsible for identifying healthcare providers to increase brand awareness and adoption of AMVUTTRA for TTR amyloidosis. This involves developing strategic account plans and collaborating with cross-functional internal teams to ensure patient access at the site of care.
Lead the development and execution of U.S. Medical Affairs strategies and community cardiology education initiatives for ATTR amyloidosis. Collaborate with cross-functional partners to create scientific content and synthesize stakeholder insights to inform medical strategy.
The MSL will build scientific partnerships with key opinion leaders and healthcare professionals to elevate disease understanding of TTR amyloidosis. They are responsible for delivering scientific information, gathering medical insights, and supporting patient accrual for clinical trials.
The Senior Manager of Medical Writing develops high-quality clinical documents and oversees the work of contract writers. They collaborate with cross-functional teams to ensure timely delivery of protocols, brochures, and regulatory reports.
The MSL will build scientific partnerships with key opinion leaders and healthcare professionals to elevate disease understanding of TTR amyloidosis. They are responsible for delivering scientific information, gathering medical insights, and supporting patient accrual for clinical trials.
The Business Account Executive is responsible for identifying healthcare providers and accounts to increase brand awareness and adoption of AMVUTTRA for TTR amyloidosis. This involves developing strategic account plans and collaborating with cross-functional internal teams to ensure patient access to care.
The Business Account Executive is responsible for identifying healthcare providers to increase brand awareness and product adoption for AMVUTTRA. This involves developing account plans, collaborating with internal stakeholders, and educating the market on TTR amyloidosis.
The Business Account Executive is responsible for identifying healthcare providers and accounts to increase brand awareness and adoption of AMVUTTRA for TTR amyloidosis. This involves developing strategic account plans and collaborating with cross-functional internal teams to optimize patient access and sales results.
Provides strategic quality oversight for internal and external nonclinical studies, including toxicology and bioanalytical data for IND submissions. Manages vendor governance, risk-based audit strategies, and the mitigation of compliance risks within the QMS.
The MSL serves as a scientific expert building peer-to-peer relationships with healthcare professionals and opinion leaders in community-based care settings. They are responsible for delivering scientific information on therapies, gathering field insights, and collaborating cross-functionally to drive patient outcomes.
Lead and manage a high-performing team of Business Account Executives to promote AMVUTTRA and increase disease awareness for hATTR amyloidosis. Provide strategic coaching, market insights, and operational leadership to meet and exceed performance targets.
The KAM is responsible for driving commercial objectives for ATTR treatments by developing and implementing strategic account plans in the Campania Nord and Molise territories. This includes identifying diagnosis centers, managing relationships with healthcare providers, and collaborating with Medical Affairs to optimize patient care.
The Business Account Executive is responsible for driving physician and patient identification and increasing brand awareness for GIVLAARI and OXLUMO within their territory. This involves executing account strategies, collaborating with internal stakeholders, and managing relationships with healthcare providers to achieve sales targets.
